NORDEN
ANNOUNCEMENT NO. 40 - 15 FEBRUARY 2021
On 4 November 2020, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2020 up to and including no later than end February 2021. For details please see announcement no. 87 of 4 November 2020.
Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 20 million (approximately DKK 126 million). Under the programme, the following transactions have been made:
Date | Number of shares | Average purchase price (DKK) | Transaction value (DKK) |
Total, last announcement | 876,000 | 112.62 | 98,652,698 |
08/2/2021 | 10,000 | 117.27 | 1,172,700 |
09/2/2021 | 15,000 | 113.98 | 1,709,700 |
10/2/2021 | 15,000 | 113.47 | 1,702,050 |
11/2/2021 | 17,000 | 115.42 | 1,962,140 |
12/2/2021 | 16,000 | 116.15 | 1,858,400 |
Accumulated | 949,000 | 112.81 | 107,057,688 |
Since the share buy-back programme was initiated on 4 November 2020, the total number of repurchased shares is 949,000 at a total amount of DKK 107,057,688.
With the transactions stated above, NORDEN holds a total of 3,308,467 treasury shares, corresponding to 8.13%. The total number of shares in NORDEN is 40,700,000 million. Adjusted for treasury shares, the number of shares is 37,391,533.
Kind regards,
Dampskibsselskabet NORDEN A/S
Klaus Nyborg
Chairman
For further information:
Klaus Nyborg, Chairman, tel.: +45 3315 0451
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
KH Group Oyj19.9.2025 14:20:51 CEST | Press release
Inside information: Carl Haglund appointed as CEO of KH Group Plc
F. Hoffmann-La Roche Ltd19.9.2025 14:15:00 CEST | Press release
CHMP recommends EU approval of Roche’s subcutaneous formulation of Lunsumio for people with relapsed or refractory follicular lymphoma
Ipsen Pharma19.9.2025 13:59:15 CEST | Press release
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
Alvotech19.9.2025 13:45:00 CEST | Press release
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
Yacht Club de Monaco19.9.2025 13:11:39 CEST | Press release
At Yacht Club de Monaco the 5th Monaco Smart & Sustainable Marina Rendezvous
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom